A single sample subcutaneous luteinizing hormone (LH)-releasing hormone (LHRH) stimulation test for monitoring LH suppression in children with central precocious puberty receiving LHRH agonists

Journal of Clinical Endocrinology and Metabolism

Volumn 84, Issue 12, 1999, Pages 4536-4540

  Lawson, Margaret L ^a   Cohen, Nini ^a  

^a CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GONADORELIN; GONADORELIN AGONIST; LEUPRORELIN; LUTEINIZING HORMONE;

ACCURACY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; LUTEINIZING HORMONE RELEASE; MALE; PRECOCIOUS PUBERTY; PRIORITY JOURNAL; SCORING SYSTEM;

EID: 0033305220     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.84.12.4536     Document Type: Article

References (15)

1. Comparison of complete and incomplete suppression of pituitary-gonadal activity in girls with central precocious puberty influence on growth and predicted adult height
2. Long-term effectiveness of depot gonadotropin-releasing hormone analogue in the treatment of children with central precocious puberty
3. Advances in the treatment of precocious puberty
4. A single-sample, subcutaneous gonadotropin-releasing hormone test for central precocious puberty
5. Tables predicting adult height from skeletal age: Revised for use with Greulich-Pyle hand standards
6. Clinical longitudinal standards for height and height velocity for North American children
7. Assessment of depot leuprolide acetate dose-adequacy for central precocious puberty
8. Efficacy of leuprolide therapy in children with central precocious puberty
9. Efficacy of depot leuprolide acetate in the treatment of central precocious puberty
10. Final height in girls with central precocious puberty: Comparison of two different luteinizing hormone-releasing hormone agonist treatments
11. Treatment of central precocious puberty: Comparison of urinary gonadotropin excretion and gonadotropin-releasing hormone (GnRH) stimulation tests in monitoring GnRH analog therapy
12. Central precocious puberty: A single blood sample after GnRH agonist administration in monitoring treatment
13. Use of an ultrasensitive recombinant cell bioassay to determine estrogen levels in girls with precocious puberty treated with a luteinizing hormone-releasing hormone agonist